Archives

Choose a date range

From To

Choose one or more categories

Categories:



Show only original CenterWatch stories

 


Ocular Therapeutix begins enrollment in phase III trial for allergic conjunctivitis

Wednesday, June 17, 2015 10:41 AM

Ocular Therapeutix, a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, has enrolled its first patients in a phase III clinical trial to evaluate the safety and efficacy of Dextenza (sustained release dexamethasone, 0.4mg) for the treatment of allergic conjunctivitis. Dextenza is administered by a physician as a bioresorbable intracanalicular depot for drug release to the ocular surface for up 30 days.

More... »

Quest Diagnostics

Report: Pharma R&D pipeline value jumps 18% to $493 billion

Wednesday, June 17, 2015 10:32 AM

Emerging therapeutic categories and a string of breakthrough drug approvals are powering key drug sales across the U.S. and Europe, fueling a projected 5% increase in global prescription sales over the next five years, according to the EvaluatePharma World Preview 2015, Outlook to 2020 report from life science market intelligence firm Evaluate. With the FDA approving an unprecedented 50 drugs in 2014, eight of which are forecast to have sales of more than $1 billion five years after launch, sustained R&D productivity may finally be within reach.

More... »


Abbott will vote its Mylan shares in favor of Mylan's proposed acquisition of Perrigo

Wednesday, June 17, 2015 09:51 AM

Abbott has confirmed its continued support for Mylan's growth strategy by stating its intent to vote its 14.5% stake in Mylan in favor of Mylan's proposed acquisition of Perrigo.

More... »

Medivir restructures, partners with GVK BIO

Wednesday, June 17, 2015 09:48 AM

Medivir, a research based pharmaceutical company based in Sweden, has announced a reorganization within its Discovery Research department, increasing its focus within the core areas of oncology and infectious diseases, and a partnership with GVK Biosciences Private (GVK BIO) of Hyderabad in India, designed to deliver enhanced efficiency and quality within its portfolio of research projects while over time reducing overall research costs and enhancing future cost flexibility.

More... »

MLSC, COBTH, UMass Med launch web portal to promote collaboration

Wednesday, June 17, 2015 09:38 AM

The Massachusetts Life Sciences Center (MLSC) partnered with the Conference of Boston Teaching Hospitals (COBTH) and the University of Massachusetts Memorial Medical Center to the launch the Massachusetts Clinical Innovation Gateway. The new web portal will allow life sciences companies from around the world to seek opportunities to partner with Massachusetts academic medical centers (AMCs) on research and clinical initiatives.

More... »

GSK launches Altius Institute for Biomedical Sciences

Wednesday, June 17, 2015 09:25 AM

GlaxoSmithKline is launching the Altius Institute for Biomedical Sciences, an independent, nonprofit research institute in Seattle. Altius will be pioneering new technologies and approaches for decoding how genes are controlled and how a cell’s “operating system” functions in health and disease. GSK expects to capitalize on rapid progress in understanding gene control to select and validate better drug targets, and to accelerate many key aspects of developing new medicines.

More... »

Bayer HealthCare, Johns Hopkins collaborate on ophthalmic therapies

Wednesday, June 17, 2015 09:24 AM

Bayer HealthCare and the Johns Hopkins University in Baltimore, Md., have entered into a five-year collaboration agreement to jointly develop new ophthalmic therapies targeting retinal diseases. The partners will jointly work on the discovery and development of innovative drugs for the treatment of serious back-of-the-eye diseases that affect many people worldwide, including age-related macular degeneration, diabetic macular edema, geographic atrophy, Stargardt's disease and retinal vein occlusion.

More... »

Quintiles launches Infosario One mobile app

Wednesday, June 17, 2015 08:46 AM

Global CRO Quintiles is extending its Quintiles Infosario technology platform with mobile access to critical clinical trial information. Using the mobile app, key stakeholders in the drug development process can conveniently access site start-up, recruitment and compliance information as well as status updates on data queries and project milestones.

More... »

Report: Innovation trends in treatments for rare diseases and widespread conditions

Wednesday, June 17, 2015 08:45 AM

The antibiotics market is at risk of losing another decade to inadequate levels of research and innovation, according to international intellectual property firm Marks & Clerk’s new report From rare to routine—medicines for rare diseases, vaccines and antibiotics. Research highlights the striking difference between research levels into rare diseases, vaccines and antibiotics across the globe.

More... »

Society for Clinical Research Sites launches program for Asia-Pac Site Solutions Summit

Wednesday, June 17, 2015 08:30 AM

The Society for Clinical Research Sites (SCRS), a global trade organization fully dedicated to representing the interests of clinical research sites, has announced a program for the 2015 Asia-Pac Site Solutions Summit. The Asia-Pac Site Solutions Summit will be July 30-31, 2015 in Melbourne, Australia. The Summit is open to clinical research investigators, site executives and industry stakeholders.

More... »

CWWeekly

June 29

FDA and PatientsLikeMe collaborate to test social media adverse event reporting

Boston-area teaching hospitals launch web portal to attract life science companies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

Integrated research partnerships build momentum
Research function provides infrastructure, leverages large pool of health systems' patients and data

'Right to Try' laws challenge clinical trial process
20 states pass, 20 more pending allowing access to study drugs without FDA and IRB approval

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

TransCelerate Biopharma turns three
High-profile consortium has made inroads fixing wasteful practices, but it still has more work ahead

Pharma industry improves its tarnished reputation
Delivering innovation, social responsibility will help rebuild trust

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs